Schedule 13G ownership disclosure
TETRALOGIC PHARMACEUTICALS COR
Security class unavailable · CUSIP: 88165U109
Event date: 2015-10-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-15-007638
- Form type
- SC 13G
- Filer
- TETRALOGIC PHARMACEUTICALS CORP
- CIK
- CIK 1361248
- Filed
- Nov 05, 2015
- Reporting period
- Oct 26, 2015
- Description
- Schedule 13G beneficial ownership